ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.06
      -0.06%
      Bitcoin
      56,746.01
      -1.05%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ocugen Inc (OCGN)

      7. Ocugen Inc (OCGN) News

      OCGN

      Ocugen (OCGN)

      Ocugen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OCGN
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      08/05/20229:24AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OCGNOcugen Inc
      08/05/20227:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCGNOcugen Inc
      08/05/20227:30AMGlobeNewswire Inc.Ocugen Provides Business Update & Second Quarter 2022 Financial ResultsNASDAQ:OCGNOcugen Inc
      07/29/20227:30AMGlobeNewswire Inc.Ocugen To Host Conference Call on Friday, August 5 at 8:30 a.m. ET to Discuss Business Updates and Second Quarter 2022 Financial ResultsNASDAQ:OCGNOcugen Inc
      07/20/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCGNOcugen Inc
      06/21/20227:00AMGlobeNewswire Inc.Ocugen Announces Publication of Positive Results of COVID-19 Vaccine Trial for Children 2-18 in The Lancet Infectious DiseasesNASDAQ:OCGNOcugen Inc
      06/14/20227:00AMGlobeNewswire Inc.Ocugen Named Among Philadelphia’s ‘2022 Best Places to Work’NASDAQ:OCGNOcugen Inc
      06/13/20227:00AMGlobeNewswire Inc.Ocugen, Inc. Announces Issuance of U.S. Patent for Treating Retinal Degenerative Diseases Using Gene TherapyNASDAQ:OCGNOcugen Inc
      06/09/20226:17PMGlobeNewswire Inc.Ocugen, Inc. to Present at BIO International Convention 2022NASDAQ:OCGNOcugen Inc
      06/07/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCGNOcugen Inc
      05/26/20226:13AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OCGNOcugen Inc
      05/24/20227:11AMGlobeNewswire Inc.Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) RecognitionNASDAQ:OCGNOcugen Inc
      05/24/20226:27AMTipRanksH.C. Wainwright Thinks Ocugen’s Stock is Going to RecoverNASDAQ:OCGNOcugen Inc
      05/23/20229:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCGNOcugen Inc
      05/23/20227:34AMGlobeNewswire Inc.Ocugen, Inc. to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:OCGNOcugen Inc
      05/23/20226:36AMGlobeNewswire Inc.Ocugen Announces FDA Removes Clinical Hold on Phase 2/3 Clinical Trial for COVAXIN™ (BBV152)NASDAQ:OCGNOcugen Inc
      05/20/20224:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OCGNOcugen Inc
      05/18/20224:07PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OCGNOcugen Inc
      05/13/20224:13PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OCGNOcugen Inc
      05/13/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCGNOcugen Inc
      05/12/20226:27AMTipRanksH.C. Wainwright Thinks Ocugen’s Stock is Going to RecoverNASDAQ:OCGNOcugen Inc
      05/09/20228:05AMTipRanksNoble Financial Keeps a Buy Rating on Ocugen (OCGN)NASDAQ:OCGNOcugen Inc
      05/06/20226:33AMGlobeNewswire Inc.Ocugen Provides Business Update and First Quarter 2022 Financial ResultsNASDAQ:OCGNOcugen Inc
      05/02/20227:37AMGlobeNewswire Inc.Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial ResultsNASDAQ:OCGNOcugen Inc
      04/29/202211:36AMGlobeNewswire Inc.Ocugen, Inc. to Present Preclinical Results at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual MeetingNASDAQ:OCGNOcugen Inc
      04/28/20224:14PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OCGNOcugen Inc
      04/25/20227:33AMGlobeNewswire Inc.Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical TrialNASDAQ:OCGNOcugen Inc
      04/20/20224:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCGNOcugen Inc
      04/19/20225:32PMGlobeNewswire Inc.Ocugen, Inc. to Present at NobleCon18NASDAQ:OCGNOcugen Inc
       Showing the most relevant articles for your search:NASDAQ:OCGN